|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4292250A
(en)
|
1980-11-17 |
1981-09-29 |
Wisconsin Alumni Research Foundation |
Vitamin D derivatives
|
|
US4675189A
(en)
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
|
US4410515A
(en)
|
1981-04-01 |
1983-10-18 |
Massachusetts General Hospital |
Vitamin D glycosides and a method of use
|
|
US4456553A
(en)
|
1982-05-07 |
1984-06-26 |
Teijin Limited |
Vitamin D3 derivatives, process for preparation thereof, and antigens comprising said derivatives to be used for preparation of antibodies for immunochemical assay and antibodies prepared therefrom
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5550111A
(en)
|
1984-07-11 |
1996-08-27 |
Temple University-Of The Commonwealth System Of Higher Education |
Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof
|
|
NZ217821A
(en)
|
1985-10-10 |
1989-07-27 |
Biotech Australia Pty Ltd |
Oral delivery system; complex of active agent and vitamin b12 or analogue thereof
|
|
JPH02274A
(ja)
|
1987-10-14 |
1990-01-05 |
Toyo Jozo Co Ltd |
新規な２５−ヒドロキシビタミンｄ↓３誘導体およびその製造法およびそれを用いた定量法
|
|
US5232836A
(en)
|
1988-05-04 |
1993-08-03 |
Ire-Medgenix S.A. |
Vitamin D derivatives: therapeutic applications and applications to assays of metabolites of vitamin D
|
|
FR2631025B1
(fr)
*
|
1988-05-04 |
1991-04-12 |
Ire Medgenix Sa |
Nouveaux derives de la vitamine d3 et application aux dosages des metabolites de la vitamine d3
|
|
US5214170A
(en)
|
1988-10-05 |
1993-05-25 |
Toyo Jozo Kabushiki Kaisha |
Radioisotope iodine-labeled 1α (or 24R), 25-dihydroxy vitamin D3
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
|
US5688488A
(en)
|
1989-04-03 |
1997-11-18 |
Purdue Research Foundation |
Composition and method for tumor imaging
|
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
|
US5122614A
(en)
|
1989-04-19 |
1992-06-16 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
|
SE509359C2
(sv)
|
1989-08-01 |
1999-01-18 |
Cemu Bioteknik Ab |
Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
|
|
US5605690A
(en)
|
1989-09-05 |
1997-02-25 |
Immunex Corporation |
Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
|
|
US7217689B1
(en)
|
1989-10-13 |
2007-05-15 |
Amgen Inc. |
Glycosylation analogs of erythropoietin
|
|
WO1993007883A1
(en)
|
1991-10-24 |
1993-04-29 |
Isis Pharmaceuticals, Inc. |
Derivatized oligonucleotides having improved uptake and other properties
|
|
US6395492B1
(en)
|
1990-01-11 |
2002-05-28 |
Isis Pharmaceuticals, Inc. |
Derivatized oligonucleotides having improved uptake and other properties
|
|
EP1690934A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
ATE300615T1
(de)
|
1990-08-29 |
2005-08-15 |
Genpharm Int |
Transgene mäuse fähig zur produktion heterologer antikörper
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5612034A
(en)
|
1990-10-03 |
1997-03-18 |
Redcell, Inc. |
Super-globuling for in vivo extended lifetimes
|
|
AU1424492A
(en)
|
1991-02-20 |
1992-09-15 |
Christopher Capelli |
Non-protein intracellular receptor binding conjugates and a method of use thereof
|
|
DK0575545T3
(da)
|
1991-03-15 |
2003-09-15 |
Amgen Inc |
Pegylering af polypeptider
|
|
US7192584B2
(en)
|
1991-03-18 |
2007-03-20 |
Centocor, Inc. |
Methods of treating psoriasis with anti-TNF antibodies
|
|
US5919452A
(en)
|
1991-03-18 |
1999-07-06 |
New York University |
Methods of treating TNFα-mediated disease using chimeric anti-TNF antibodies
|
|
WO1993012145A1
(en)
|
1991-12-19 |
1993-06-24 |
Baylor College Of Medicine |
Pva or peg conjugates of peptides for epitope-specific immunosuppression
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
US5447851B1
(en)
|
1992-04-02 |
1999-07-06 |
Univ Texas System Board Of |
Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
|
|
US5470949A
(en)
|
1992-12-15 |
1995-11-28 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method for making amino acid glycosides and glycopeptides
|
|
US5548064A
(en)
|
1993-05-24 |
1996-08-20 |
Biotech Australia Pty Limited |
Vitamin B12 conjugates with EPO, analogues thereof and pharmaceutical compositions
|
|
US6342225B1
(en)
|
1993-08-13 |
2002-01-29 |
Deutshces Wollforschungsinstitut |
Pharmaceutical active conjugates
|
|
JPH09509428A
(ja)
|
1994-02-23 |
1997-09-22 |
カイロン コーポレイション |
薬理学的に活性な薬剤の血清半減期を増加させるための方法および組成物
|
|
US6919441B2
(en)
|
1994-03-14 |
2005-07-19 |
Aventis Pharma Deutschland Gmbh |
Polyamide-oligonucleotide derivatives, their preparation and use
|
|
US5629384A
(en)
|
1994-05-17 |
1997-05-13 |
Consiglio Nazionale Delle Ricerche |
Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces
|
|
US5574018A
(en)
|
1994-07-29 |
1996-11-12 |
Amgen Inc. |
Conjugates of vitamin B12 and proteins
|
|
PT804456E
(pt)
|
1994-10-06 |
2003-01-31 |
Peter Eigil Nielsen |
Conjugados de acidos nucleicos dos peptidos
|
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
US5739277A
(en)
|
1995-04-14 |
1998-04-14 |
Genentech Inc. |
Altered polypeptides with increased half-life
|
|
CA2219361C
(en)
|
1995-04-27 |
2012-02-28 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
EP0823941A4
(en)
|
1995-04-28 |
2001-09-19 |
Abgenix Inc |
HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
|
|
DE873126T1
(de)
|
1995-12-29 |
2000-11-02 |
A And D Assay, Inc. |
Markierte vitamin d-verbindungen und deren verwendung
|
|
GB9526733D0
(en)
|
1995-12-30 |
1996-02-28 |
Delta Biotechnology Ltd |
Fusion proteins
|
|
US5691328A
(en)
|
1996-02-02 |
1997-11-25 |
Clarion Pharmaceuticals Inc. |
Phosphoethanolamine conjugates of vitamin D compounds
|
|
AU2538797A
(en)
|
1996-03-22 |
1997-10-10 |
Trustees Of Boston University |
Photodynamic therapy using nuclear hormone receptors to target photosensitizers
|
|
EP1500329B1
(en)
|
1996-12-03 |
2012-03-21 |
Amgen Fremont Inc. |
Human antibodies that specifically bind human TNF alpha
|
|
JP2001511811A
(ja)
*
|
1997-02-13 |
2001-08-14 |
ボーン ケア インターナショナル インコーポレイテッド |
ビタミンｄ化合物の標的治療放出
|
|
US20030129194A1
(en)
|
1997-02-13 |
2003-07-10 |
Bone Care International, Inc. |
Targeted therapeutic delivery of vitamin D compounds
|
|
US6093701A
(en)
|
1997-12-12 |
2000-07-25 |
Mirus, Inc. |
Method for covalent attachment of compounds to genes
|
|
ES2347027T3
(es)
|
1998-05-22 |
2010-10-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Moleculas bifuncionales y terapias basadas en las mismas.
|
|
US6537806B1
(en)
|
1998-06-02 |
2003-03-25 |
University Of Washington |
Compositions and methods for treating diabetes
|
|
WO1999067211A1
(de)
|
1998-06-25 |
1999-12-29 |
Immundiagnostik Gesellschaft Für Produktion Und Vertrieb Von Labordiagnostika Mbh |
FUNKTIONELLE VITAMIN-D-DERIVATE UND VERFAHREN ZUR BESTIMMUNG VON 25-HYDROXY- UND 1α,25-DIHYDROXY-VITAMIN-D
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
ES2257287T3
(es)
|
1999-02-12 |
2006-08-01 |
Amgen Inc. |
Composiciones de leptina glicosiladas y metodos relacionados.
|
|
US6713280B1
(en)
|
1999-04-07 |
2004-03-30 |
Thomas Jefferson University |
Enhancement of peptide cellular uptake
|
|
AUPQ014699A0
(en)
|
1999-05-04 |
1999-05-27 |
Access Pharmaceuticals Australia Pty Limited |
Amplification of folate-mediated targeting to tumor cells using nanoparticles
|
|
PT1105409E
(pt)
|
1999-05-17 |
2006-07-31 |
Conjuchem Inc |
Proteccao de peptidos terapeuticos endogenos da actividade de peptidases por conjugacao a componentes do sangue
|
|
CA2363712C
(en)
|
1999-05-17 |
2011-05-10 |
Conjuchem Inc. |
Long lasting insulinotropic peptides
|
|
US6887470B1
(en)
|
1999-09-10 |
2005-05-03 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
AUPQ071299A0
(en)
|
1999-06-02 |
1999-06-24 |
Access Pharmaceuticals Australia Pty Limited |
Vitamin directed dual targeting therapy
|
|
KR100827973B1
(ko)
|
1999-07-23 |
2008-05-21 |
겐지 간가와 |
신규 펩티드
|
|
EP2180054A1
(en)
|
1999-12-24 |
2010-04-28 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
BR0116024A
(pt)
|
2000-12-07 |
2005-12-13 |
Lilly Co Eli |
Proteìna de fusão heteróloga e uso da mesma
|
|
CN1491233A
(zh)
|
2001-02-02 |
2004-04-21 |
康久化学公司 |
长效生长激素释放因子衍生物
|
|
ATE396202T1
(de)
|
2001-02-16 |
2008-06-15 |
Conjuchem Biotechnologies Inc |
Lang wirkendes glucagon-ähnliches peptid-2 für die behandlung von gastrointestinalen krankheiten und störungen
|
|
US7211395B2
(en)
|
2001-03-09 |
2007-05-01 |
Dyax Corp. |
Serum albumin binding moieties
|
|
US7741453B2
(en)
|
2001-05-31 |
2010-06-22 |
Conjuchem Biotechnologies, Inc. |
Long lasting fusion peptide inhibitors for HIV infection
|
|
WO2003011213A2
(en)
|
2001-07-30 |
2003-02-13 |
Eli Lilly And Company |
Method for treating diabetes and obesity
|
|
JP2004537580A
(ja)
|
2001-08-10 |
2004-12-16 |
エピックス メディカル， インコーポレイテッド |
延長された循環半減期を有するポリペプチド結合体
|
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
|
AU2002362312A1
(en)
|
2001-09-17 |
2003-04-01 |
Mayo Foundation For Medical Education And Research |
Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof
|
|
US6858227B1
(en)
|
2001-11-21 |
2005-02-22 |
Sonus Pharmaceuticals, Inc. |
Vitamin E conjugates
|
|
EP2261250B1
(en)
|
2001-12-21 |
2015-07-01 |
Human Genome Sciences, Inc. |
GCSF-Albumin fusion proteins
|
|
US20040186063A1
(en)
|
2002-02-15 |
2004-09-23 |
Hans-Jurgen Gutke |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
|
AU2003219770B2
(en)
|
2002-02-15 |
2008-10-09 |
Merckle Gmbh |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
|
US7591994B2
(en)
*
|
2002-12-13 |
2009-09-22 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
|
DE10209821A1
(de)
*
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung von Proteinen an ein modifiziertes Polysaccharid
|
|
MXPA04011247A
(es)
|
2002-07-19 |
2005-02-17 |
Cytos Biotechnology Ag |
Conjugados portadores de grelina.
|
|
AU2003254119B2
(en)
|
2002-07-23 |
2007-11-29 |
Ipsen Pharma S.A.S. |
Ghrelin analogs
|
|
AU2003246500A1
(en)
|
2002-07-31 |
2004-02-16 |
Conjuchem Biotechnologies Inc. |
Long lasting natriuretic peptide derivatives
|
|
CA2499075A1
(en)
|
2002-09-16 |
2004-03-25 |
Elusys Therapeutics, Inc. |
Production of bispecific molecules using polyethylene glycol linkers
|
|
CA2505316C
(en)
|
2002-11-08 |
2014-08-05 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
US20040191196A1
(en)
|
2002-12-16 |
2004-09-30 |
Dov Tamarkin |
Novel conjugate compounds and dermatological compositions thereof
|
|
US20040132104A1
(en)
|
2003-01-07 |
2004-07-08 |
Sackrison James L. |
Vitamin D assay
|
|
DK1592457T3
(da)
|
2003-01-27 |
2012-10-22 |
Endocyte Inc |
Folat-vinblastin-konjugat som lægemiddel
|
|
CN100381177C
(zh)
*
|
2003-01-27 |
2008-04-16 |
恩多塞特公司 |
维生素受体结合递药缀合物
|
|
KR20060003862A
(ko)
|
2003-03-14 |
2006-01-11 |
네오스 테크놀로지스, 인크. |
수용성분기폴리머 및 그 접합체
|
|
DE602004021603D1
(de)
|
2003-07-25 |
2009-07-30 |
Conjuchem Biotechnologies Inc |
Insulinderivative mit langanhaltender wirkung und verfahren zu deren herstellung
|
|
US20060193821A1
(en)
|
2004-03-05 |
2006-08-31 |
Diener John L |
Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics
|
|
CA2560956A1
(en)
|
2004-03-29 |
2005-10-20 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Amphipathic glycopeptides
|
|
WO2005105071A1
(en)
|
2004-04-30 |
2005-11-10 |
Ben Gurion University Of The Negev Research And Development Authority Ltd. |
A topical composition containing a vitamin d derivative
|
|
WO2005113571A2
(en)
|
2004-05-13 |
2005-12-01 |
The University Of North Carolina At Chapel Hill |
Methods for the delivery of oligomeric compounds
|
|
US7906137B2
(en)
|
2004-05-21 |
2011-03-15 |
Mediplex Corporation, Korea |
Delivery agents for enhancing mucosal absorption of therapeutic agents
|
|
US20060045880A1
(en)
|
2004-08-23 |
2006-03-02 |
Krieg Paul A |
Methods for modulating angiogenesis and apoptosis with apelin compositions
|
|
WO2006081249A2
(en)
|
2005-01-25 |
2006-08-03 |
Cell Therapeutics, Inc. |
Conjugates of biologically active proteins having a modified in vivo half-life
|
|
US7833979B2
(en)
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
US20060246523A1
(en)
*
|
2005-04-28 |
2006-11-02 |
Christopher Bieniarz |
Antibody conjugates
|
|
WO2006122787A1
(en)
|
2005-05-18 |
2006-11-23 |
Ablynx Nv |
Serum albumin binding proteins
|
|
CA2658673A1
(en)
|
2005-07-27 |
2008-02-01 |
Gerald J. Prud'homme |
Composition and method for prevention and treatment of type i and type ii diabetes
|
|
JP2009509992A
(ja)
|
2005-09-29 |
2009-03-12 |
エフ．ホフマン−ラ ロシュ アーゲー |
２５−ヒドロキシビタミンｄに対する抗体
|
|
KR20080072639A
(ko)
|
2005-10-27 |
2008-08-06 |
주식회사 펩트론 |
생리활성 기질-혈액 단백질 복합체 및 이를 이용하는생리활성 기질의 안정화 방법
|
|
WO2007097934A2
(en)
|
2006-02-17 |
2007-08-30 |
Elusys Therapeutics, Inc. |
Methods and compositions for using erythrocytes as carriers for delivery of drugs
|
|
EP1996937A4
(en)
|
2006-03-06 |
2009-04-08 |
Amunix Inc |
GENETIC PACKS AND USES THEREOF
|
|
EP2012809B1
(en)
|
2006-03-10 |
2013-05-22 |
Ipsen Pharma |
Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment
|
|
GB0616111D0
(en)
|
2006-06-16 |
2006-09-20 |
Ardana Bioscience Ltd |
Agents, methods and uses
|
|
WO2008036841A2
(en)
|
2006-09-22 |
2008-03-27 |
Dharmacon, Inc. |
Tripartite oligonucleotide complexes and methods for gene silencing by rna interference
|
|
US7982018B2
(en)
|
2006-10-16 |
2011-07-19 |
Conjuchem, Llc |
Modified corticotropin releasing factor peptides and uses thereof
|
|
WO2008101231A2
(en)
|
2007-02-16 |
2008-08-21 |
Endocyte, Inc. |
Methods and compositions for treating and diagnosing kidney disease
|
|
AU2008223431B2
(en)
|
2007-03-05 |
2013-06-13 |
Syracuse University |
A conjugate of insulin and vitamin B12 for oral delivery
|
|
CN104127878A
(zh)
|
2007-03-14 |
2014-11-05 |
恩多塞特公司 |
结合配体连接的微管溶素递药缀合物
|
|
DK2308514T3
(da)
|
2007-03-23 |
2013-09-02 |
To Bbb Holding B V |
Konjugater til målrettet lægemiddeltransport gennem blod-hjerne barrieren
|
|
AU2008257448B9
(en)
|
2007-05-31 |
2013-07-11 |
Alize Pharma Sas |
Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders
|
|
BRPI0812970A2
(pt)
|
2007-06-25 |
2019-09-24 |
Endocyte Inc |
conjugados contendo espaçadores hidrofílicos
|
|
WO2009045457A2
(en)
|
2007-10-02 |
2009-04-09 |
Rxi Pharmaceuticals Corp. |
Tripartite rnai constructs
|
|
US8076476B2
(en)
|
2007-11-15 |
2011-12-13 |
Avi Biopharma, Inc. |
Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits
|
|
TWI489994B
(zh)
|
2008-03-17 |
2015-07-01 |
Baxter Healthcare Sa |
供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
|
|
ES2563553T3
(es)
|
2008-04-01 |
2016-03-15 |
Novo Nordisk A/S |
Conjugados de insulina-albúmina
|
|
CN101809029B
(zh)
|
2008-05-23 |
2016-06-15 |
第一三共株式会社 |
具有延长目标肽的血浆半衰期作用的肽
|
|
EP2296690B1
(en)
|
2008-06-04 |
2016-11-30 |
Amgen, Inc |
Fgf21 mutants and uses thereof
|
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
|
EP3412300A1
(en)
|
2008-06-27 |
2018-12-12 |
Duke University |
Therapeutic agents comprising elastin-like peptides
|
|
EP2341942A1
(en)
|
2008-09-19 |
2011-07-13 |
Nektar Therapeutics |
Polymer conjugates of therapeutic peptides
|
|
CA2746527A1
(en)
|
2008-09-22 |
2010-03-25 |
Rxi Pharmaceuticals Corporation |
Rna interference in skin indications
|
|
CN102307905B
(zh)
|
2008-12-10 |
2015-11-25 |
斯克利普斯研究院 |
利用化学反应性非天然氨基酸产生载体-肽偶联物
|
|
US20120028887A1
(en)
|
2009-04-01 |
2012-02-02 |
Yeda Research And Development Co. Ltd. |
Lipopeptide inhibitors of hiv-1
|
|
WO2010123290A2
(ko)
|
2009-04-22 |
2010-10-28 |
(주)알테오젠 |
체내 지속성을 유지함으로 체내 반감기가 증가된 단백질 또는 펩티드 융합체, 및 이를 이용하여 체내 반감기를 증가시키는 방법
|
|
HRP20240135T1
(hr)
|
2009-05-05 |
2024-04-12 |
Amgen Inc. |
Fgf21 mutanti i njihove upotrebe
|
|
EP2427207B1
(en)
|
2009-05-05 |
2017-08-16 |
Amgen, Inc |
Fgf21 mutants and uses thereof
|
|
US20120165377A1
(en)
|
2009-09-28 |
2012-06-28 |
Kowa Co., Ltd. |
Agent for reducing visceral fat weight
|
|
US20110097733A1
(en)
|
2009-10-27 |
2011-04-28 |
Michel Anciaux |
Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin d metabolite
|
|
EP2695617B1
(en)
|
2009-12-23 |
2019-01-09 |
Glycomyr Inc. |
Vitamin D glycosides and sulfates for treating intestinal diseases
|
|
CN118767117A
(zh)
|
2010-01-22 |
2024-10-15 |
诺沃—诺迪斯克保健股份有限公司 |
体内功效延长的生长激素
|
|
EP2552967A4
(en)
|
2010-04-02 |
2014-10-08 |
Amunix Operating Inc |
BINDING FUSION PROTEINS, BINDING FUSION PROTEIN MEDICINAL CONJUGATES, XTEN MEDICAMENT CONJUGATES, AND METHOD FOR THEIR PREPARATION AND USE
|
|
BR112012029611A2
(pt)
|
2010-05-21 |
2017-07-25 |
Merrimack Pharmaceuticals Inc |
proteína de fusão biespecífica, composição farmacêutica, método de tratamento de dano ao tecido em um indivíduo, método de promoção da regeração ou sobrevivência do tecido em um indivíduo e molécula de ácido nucleico
|
|
US9377466B2
(en)
|
2010-09-06 |
2016-06-28 |
Modpro Ab |
Compounds and methods
|
|
EP3842074A1
(en)
*
|
2010-09-29 |
2021-06-30 |
Philogen S.p.A. |
Protein-drug conjugates
|
|
US9023791B2
(en)
|
2010-11-19 |
2015-05-05 |
Novartis Ag |
Fibroblast growth factor 21 mutations
|
|
CN103796666B
(zh)
|
2011-05-18 |
2018-07-06 |
欧莫德里斯制药公司 |
改良的肽药物
|
|
US8785603B2
(en)
|
2011-05-20 |
2014-07-22 |
Siemens Healthcare Diagnostics Inc. |
Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof
|
|
EP3453761A1
(en)
|
2011-08-29 |
2019-03-13 |
Ionis Pharmaceuticals, Inc. |
Oligomer-conjugate complexes and their use
|
|
MX2014002260A
(es)
|
2011-08-31 |
2014-08-18 |
Amgen Inc |
Factor de crecimiento de fibroblasto 21 para usar en el tratamiento de diabetes tipo 1.
|
|
EP2755675B1
(en)
|
2011-09-12 |
2018-06-06 |
Amunix Operating Inc. |
Glucagon-like peptide-2 compositions and methods of making and using same
|
|
TW201315742A
(zh)
|
2011-09-26 |
2013-04-16 |
Novartis Ag |
治療代謝病症之雙功能蛋白質
|
|
US20140256626A1
(en)
|
2011-10-18 |
2014-09-11 |
Prolynx Llc |
Peg conjugates of exenatide
|
|
JP6165168B2
(ja)
|
2011-12-22 |
2017-07-19 |
ファイザー・インク |
抗糖尿病化合物
|
|
US9475856B2
(en)
|
2012-03-02 |
2016-10-25 |
New York University |
Chimeric FGF21 proteins with enhanced binding affinity for β-klotho for the treatment of type II diabetes, obesity, and related metabolic disorders
|
|
US20150111246A1
(en)
|
2012-04-24 |
2015-04-23 |
Astrazeneca Pharmaceuticals Lp |
Site-specific enzymatic modification of exendins and analogs thereof
|
|
CN108524919A
(zh)
|
2012-05-17 |
2018-09-14 |
延伸生物科学股份有限公司 |
用于改进的药物递送的载体
|
|
US9464126B2
(en)
|
2012-06-07 |
2016-10-11 |
New York University |
Chimeric fibroblast growth factor 21 proteins and methods of use
|
|
AU2013314405A1
(en)
|
2012-09-11 |
2015-04-09 |
Unisense Diagnostics Aps |
Detection of non-nucleic acid analytes using strand displacement exchange reactions
|
|
DK2922877T3
(da)
|
2012-11-20 |
2019-01-02 |
Eumederis Pharmaceuticals Inc |
Forbedrede peptidlægemidler
|
|
US9290557B2
(en)
|
2012-11-28 |
2016-03-22 |
Ngm Biopharmaceuticals, Inc. |
Compositions comprising variants and fusions of FGF19 polypeptides
|
|
US9244083B2
(en)
|
2012-11-30 |
2016-01-26 |
Siemens Healthcare Diagnostics Inc. |
Compositions and methods for detecting vitamin D
|
|
CN105008393A
(zh)
|
2012-12-10 |
2015-10-28 |
弗莱德哈钦森癌症研究中心 |
用于筛选的方法
|
|
US20140200261A1
(en)
|
2013-01-17 |
2014-07-17 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
|
SI3793586T1
(sl)
*
|
2018-05-16 |
2024-07-31 |
Csl Limited |
Različice receptorja za topni komplement tipa 1 in njihova uporaba
|